BD KIESTRA¿ IDENTIFA
Report
- Report Number
- 3010141591-2024-00008
- Event Type
- Malfunction
- Date Received
- December 9, 2024
- Date of Event
- November 30, 2024
- Report Date
- July 29, 2025
- Manufacturer
- BD KIESTRA LAB AUTOMATION
- Product Code
- QBN
- UDI-DI
- 00382904440633
- PMA / PMN Number
- K191964
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
D2. ADDITIONAL MEDICAL DEVICE TYPE: QQV. COMMON DEVICE NAME: AUTOMATED SYSTEM FOR SAMPLE PREPARATION AND IDENTIFICATION OF MICROORGANISMS FROM CULTURED ISOLATES BY MASS SPECTROMETRY G5. ADDITIONAL 510K: K222563. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.
H.6. INVESTIGATION SUMMARY: THIS STATEMENT IS TO SUMMARIZE THE INVESTIGATION OF A COMPLAINT INVOLVING THE BD KIESTRA IDENTIFA. ACCORDING TO THE INFORMATION PROVIDED, THE CUSTOMER REPORTED THAT THE MALDI SYSTEM GAVE INCORRECT BACTERIAL IDENTIFICATIONS AFTER THE TARGET PLATE WAS REMOVED FROM THE IDENTIFA SYSTEM. THESE MISIDENTIFICATIONS WERE CONFIRMED BY COMPARING THE MALDI RESULTS WITH MANUAL VERIFICATION USING THE VITEK SYSTEM, WHICH PROVIDED THE CORRECT BACTERIAL STRAINS. DURING THE INVESTIGATION, THE FIELD SERVICE ENGINEER (FSE) CONFIRMED THAT THE MALDI SYSTEM HAD PREVIOUSLY PRODUCED INCORRECT RESULTS FOR SEVERAL ISOLATES. THE FSE PERFORMED MAINTENANCE ON THE DEVICE. UPON RE-EVALUATION, THE ISSUE COULD NOT BE REPRODUCED, AND NO NEW OCCURRENCES WERE REPORTED. BASED ON THIS, THE CASE WAS CLOSED. FOLLOWING THIS ACTION, NO FURTHER ISSUES WERE ENCOUNTERED. BASED ON THE INVESTIGATION, THIS CASE HAS BEEN ASSESSED AS CONFIRMED FOR A BD QUALITY ISSUE. NO NEW TRENDS, RISKS, OR HAZARDS WERE IDENTIFIED AS A RESULT OF THIS COMPLAINT. THE ISSUE IN THIS COMPLAINT DOES NOT REQUIRE THE INITIATION OF A CORRECTIVE AND PREVENTATIVE ACTION (CAPA). A DESIGN HISTORY RECORD (DHR) REVIEW IS NOT REQUIRED FOR THIS COMPLAINT. THE COMPLAINT WAS EVALUATED VIA OTHER ELEMENTS OF THE INVESTIGATION. THE RESULTS OF THIS EVALUATION HAVE NOT IDENTIFIED ANY NEW HAZARDS, NEW RISKS, OR SPECIFIC TRENDS. BD QUALITY WILL CONTINUE TO CLOSELY MONITOR TRENDS ASSOCIATED WITH THIS ISSUE.
IT WAS REPORTED THAT FOUR SPECIMENS THAT WERE PREPARED ON THE BD KIESTRA¿ IDENTIFA GAVE FALSE IDENTIFICATION RESULTS: ENTEROCOCCI WAS IDENTIFIED AS STAPHYLOCOCCUS. ENTEROCOCCI WAS IDENTIFIED AS ECOLI. PROTEUS WAS IDENTIFIED AS STAPH. HEMOLYTICUS. E. COLI WAS IDENTIFIED AS STR. CONSTELLATUS THERE WAS NO REPORT OF PATIENT IMPACT.
IT WAS REPORTED THAT FOUR SPECIMENS THAT WERE PREPARED ON THE BD KIESTRA¿ IDENTIFA GAVE FALSE IDENTIFICATION RESULTS: ENTEROCOCCI WAS IDENTIFIED AS STAPHYLOCOCCUS ENTEROCOCCI WAS IDENTIFIED AS ECOLI PROTEUS WAS IDENTIFIED AS STAPH. HEMOLYTICUS E. COLI WAS IDENTIFIED AS STR. CONSTELLATUS THERE WAS NO REPORT OF PATIENT IMPACT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2534783 | BD KIESTRA¿ IDENTIFA | SEE H11 | QBN | BD KIESTRA LAB AUTOMATION | 00382904440633 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |